Currently out of the existing stock ratings of Ananda Ghosh, 25 are a BUY (92.59%), 2 are a HOLD (7.41%).

Ananda Ghosh

Work Performance Price Targets & Ratings Chart

Analyst Ananda Ghosh, carries an average stock price target met ratio of 18.88% that have a potential upside of 41.8% achieved within 44 days.

Ananda Ghosh’s has documented 53 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on DYN, Dyne Therapeutics at 30-Sep-2026.

Wall Street Analyst Ananda Ghosh

Analyst best performing recommendations are on GPCR (STRUCTURE THERAPEUTICS).
The best stock recommendation documented was for GPCR (STRUCTURE THERAPEUTICS) at 8/7/2025. The price target of $60 was fulfilled within 123 days with a profit of $43.8 (270.37%) receiving and performance score of 21.98.

Average potential price target upside

GPCR Structure Therapeutics IVA Inventiva Sa RNA Avidity Biosciences ACAD ACADIA Pharmaceuticals DYN Dyne Therapeutics PEPG PepGen Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Oct-2023

$110

$88.81 (419.11%)

$110

1 months 19 days ago
(09-Sep-2026)

10/15 (66.67%)

$68.77 (166.80%)

489

Buy Since 02-May-2025

$97

$75.81 (357.76%)

$100

2 months 21 days ago
(07-Aug-2026)

1/3 (33.33%)

$43.86 (82.54%)

220

Buy Since 20-Dec-2024

$70

$20.29 (40.82%)

$100

4 months 17 days ago
(11-Jun-2026)

3/6 (50%)

$26.7 (61.66%)

229

Buy Since 09-Apr-2024

$101

$79.81 (376.64%)

$101

4 months 21 days ago
(07-Jun-2026)

14/16 (87.5%)

$63.42 (168.76%)

433

Buy Since 28-Feb-2023

$145

$123.81 (584.29%)

$145

4 months 23 days ago
(05-Jun-2026)

4/10 (40%)

$107.42 (285.84%)

412

Show more analysts

Please expand the browser size to see the chart

Which stock is Ananda Ghosh most bullish on?

Potential upside of $48.81 has been obtained for GPCR (STRUCTURE THERAPEUTICS)

Which stock is Ananda Ghosh most reserved on?

Potential downside of $13.27 has been obtained for ACAD (ACADIA PHARMACEUTICALS)
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?